BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9858882)

  • 1. Cisplatin sensitivity in cAMP-dependent protein kinase mutants of Saccharomyces cerevisiae.
    Cvijic ME; Yang WL; Chin KV
    Anticancer Res; 1998; 18(5A):3187-92. PubMed ID: 9858882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.
    Liu B; Cvijic ME; Jetzt A; Chin KV
    Cell Growth Differ; 1996 Aug; 7(8):1105-12. PubMed ID: 8853907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of RIalpha overexpression on cisplatin sensitivity in human ovarian carcinoma cells.
    Cvijic ME; Chin KV
    Biochem Biophys Res Commun; 1998 Aug; 249(3):723-7. PubMed ID: 9731205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants.
    Cvijic ME; Chin KV
    Cell Growth Differ; 1997 Dec; 8(12):1243-7. PubMed ID: 9419412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line.
    Schenk PW; Boersma AW; Brandsma JA; den Dulk H; Burger H; Stoter G; Brouwer J; Nooter K
    Cancer Res; 2001 Oct; 61(19):6982-6. PubMed ID: 11585720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic isoforms Tpk1 and Tpk2 of Candida albicans PKA have non-redundant roles in stress response and glycogen storage.
    Giacometti R; Kronberg F; Biondi RM; Passeron S
    Yeast; 2009 May; 26(5):273-85. PubMed ID: 19391100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature and transcriptional role of catalytic subunits of yeast mitochondrial cAMP-dependent protein kinase.
    Rahman MU; Hudson AP
    Biochem Biophys Res Commun; 1995 Jan; 206(2):756-63. PubMed ID: 7826397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross regulation between Candida albicans catalytic and regulatory subunits of protein kinase A.
    Giacometti R; Kronberg F; Biondi RM; Hernández AI; Passeron S
    Fungal Genet Biol; 2012 Jan; 49(1):74-85. PubMed ID: 22198055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill.
    Schenk PW; Brok M; Boersma AW; Brandsma JA; Den Dulk H; Burger H; Stoter G; Brouwer J; Nooter K
    Mol Pharmacol; 2003 Aug; 64(2):259-68. PubMed ID: 12869630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered drug sensitivities to anticancer agents in radiation-sensitive DNA repair deficient yeast mutants.
    Abe H; Wada M; Kohno K; Kuwano M
    Anticancer Res; 1994; 14(5A):1807-10. PubMed ID: 7531413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-dependent activation of protein kinase A activity in Saccharomyces cerevisiae and phosphorylation of its TPK1 catalytic subunit.
    Portela P; Moreno S
    Cell Signal; 2006 Jul; 18(7):1072-86. PubMed ID: 16226873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The level of cAMP-dependent protein kinase A activity strongly affects osmotolerance and osmo-instigated gene expression changes in Saccharomyces cerevisiae.
    Norbeck J; Blomberg A
    Yeast; 2000 Jan; 16(2):121-37. PubMed ID: 10641035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin.
    Cvijic ME; Chin KV
    Int J Cancer; 1997 Jul; 72(2):345-50. PubMed ID: 9219844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae.
    Huang RY; Eddy M; Vujcic M; Kowalski D
    Cancer Res; 2005 Jul; 65(13):5890-7. PubMed ID: 15994967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKA-chromatin association at stress responsive target genes from Saccharomyces cerevisiae.
    Baccarini L; Martínez-Montañés F; Rossi S; Proft M; Portela P
    Biochim Biophys Acta; 2015 Nov; 1849(11):1329-39. PubMed ID: 26403272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrates for yeast mitochondrial cAMP-dependent protein kinase activity.
    Rahman MU; Hudson AP
    Biochem Biophys Res Commun; 1995 Sep; 214(1):188-94. PubMed ID: 7669038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatin.
    Burger H; Capello A; Schenk PW; Stoter G; Brouwer J; Nooter K
    Biochem Biophys Res Commun; 2000 Mar; 269(3):767-74. PubMed ID: 10720490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic screening in vivo reveals the role played by vacuolar H+ ATPase and cytosolic acidification in sensitivity to DNA-damaging agents such as cisplatin.
    Liao C; Hu B; Arno MJ; Panaretou B
    Mol Pharmacol; 2007 Feb; 71(2):416-25. PubMed ID: 17093137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential localization to cytoplasm, nucleus or P-bodies of yeast PKA subunits under different growth conditions.
    Tudisca V; Recouvreux V; Moreno S; Boy-Marcotte E; Jacquet M; Portela P
    Eur J Cell Biol; 2010 Apr; 89(4):339-48. PubMed ID: 19804918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel function of the regulatory subunit of protein kinase A: regulation of cytochrome c oxidase activity and cytochrome c release.
    Yang WL; Iacono L; Tang WM; Chin KV
    Biochemistry; 1998 Oct; 37(40):14175-80. PubMed ID: 9760254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.